TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
CSTL

Castle Biosciences Inc

Healthcare · Diagnostics & Research

34.90$ +0.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow CSTL
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-88.9% -54.0% 13.5% 15.7% -20.2% -30.4% -2.6% 19.5% 18.7%
2.3% 1.4% 0.7% 0.8% 3.6% 7.7% 5.6% 4.8% 11.8%
0.8% 1.3% 2.4% 13.3% 23.1% 26.5% 23.3% 15.2% 13.3%
-1.2% 2.4% -1.1% 15.5% 13.8% 10.9% – – –
-4.7% -32.3% 0.1% 14.6% -4.4% 0.0% -3.0% -4.3% 4.0%
3.6% 1.2% 1.8% 7.6% 3.7% 4.1% 6.2% 8.5% 10.5%
-3.6% -1.2% -1.8% -7.6% -70.8% -121.5% -7.4% -15.1% -17.5%
0.0% 0.0% – – 3.3% 1.2% – – –
2.1% 45.7% 129.5% – -0.8% -1.2% -2.3% – –
187.0% 23.8% 40.3% -43.7% 0.0% -0.1% -0.1% 3.0% 0.0%
64.5% 69.5% 170.2% 488.3% 5.8% 1.1% -1.0% 1.8% -2.0%
-28.1% 14.3% 181.9% 496.4% -85.3% -150.8% -11.0% 6.3% -0.9%
-92.5% -55.2% 11.7% 8.2% -23.9% -34.5% -8.8% 11.0% 8.2%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?